• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, June 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Discovered the sixth DNA base?

Bioengineer by Bioengineer
May 4, 2015
in Cancer, Epigenomics
Reading Time: 2 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

DNA (deoxyribonucleic acid) is the main component of our genetic material. It is formed by combining four parts: A, C, G and T (adenine, cytosine, guanine and thymine), called bases of DNA combine in thousands of possible sequences to provide the genetic variability that enables the wealth of aspects and functions of living beings.

Two more bases: the Methyl- cytosine and Methyl-adenine

In the early 80s, to these four “classic” bases of DNA was added a fifth: the methyl-cytosine (mC) derived from cytosine. And it was in the late 90’s when mC was recognized as the main cause of epigenetic mechanisms: it is able to switch genes on or off depending on the physiological needs of each tissue.

In recent years, interest in this fifth DNA base has increased by showing that alterations in the methyl-cytosine contribute to the development of many human diseases, including cancer.

Today, an article published in Cell by Manel Esteller, director of the Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute (IDIBELL), ICREA researcher and Professor of Genetics at the University of Barcelona, describes the possible existence of a sixth DNA base, the methyl-adenine (mA), which also help determine the epigenome and would therefore be key in the life of the cells.

In bacteria and in complex organisms

“It was known for years that bacteria, evolutionarily very distant living organisms of us, had mA in its genome with a protective function against the insertion of genetic material from other organisms. But it was believed that this was a phenomenon of primitive cells and it was very static” describes Manel Esteller.

“However, this issue of CELL publishes three papers suggesting that more complex cells called eukaryotes such as the human body cells, also present the sixth DNA base. These studies suggest that algae, worms and flies possess mA and it acts to regulate the expression of certain genes, thus constituting a new epigenetic mark. This work has been possible thanks to the development of analytical methods with high sensitivity because levels of mA in described genomes are low. In addition it seems that mA would play a specific role in stem cells and early stages of development, “explains the researcher.

“Now the challenge we face is to confirm this data and find out whether mammals, including humans, we also have this sixth DNA base, and consider what its role is”.

Story Source:

The above story is based on materials provided by Institut d’Investigació Biomèdica de Bellvitge.
Photo Credit: DNA by Rxedox

Share12Tweet8Share2ShareShareShare2

Related Posts

Organ Preservation in Lung Cancer: Extended Sleeve Lobectomy Following Neoadjuvant Immunochemotherapy Emerges as Optimal Strategy for Centrally Located NSCLC

Organ Preservation in Lung Cancer: Extended Sleeve Lobectomy Following Neoadjuvant Immunochemotherapy Emerges as Optimal Strategy for Centrally Located NSCLC

June 24, 2025
PD-L1 targeting molecular imaging in head and neck carcinoma: A head-to-head comparison of [18F]AlF-NOTA-PCP2 PET and [18F]FDG PET/CT.

SNMMI Image of the Year: Novel Immuno-PET Tracer Outperforms FDG PET in Predicting PD-L1 Expression in Head and Neck Cancer

June 24, 2025

‘Pill-on-a-Thread’ May Replace Endoscopies for 50% of Esophageal Cancer Surveillance Patients

June 24, 2025

New ImmunoPET Tracer Boosts Early Liver Cancer Detection

June 24, 2025
Please login to join discussion

POPULAR NEWS

  • Green brake lights in the front could reduce accidents

    Study from TU Graz Reveals Front Brake Lights Could Drastically Diminish Road Accident Rates

    161 shares
    Share 64 Tweet 40
  • Pancreatic Cancer Vaccines Eradicate Disease in Preclinical Studies

    72 shares
    Share 29 Tweet 18
  • Enhancing Broiler Growth: Mannanase Boosts Performance with Reduced Soy and Energy

    66 shares
    Share 26 Tweet 17
  • How Scientists Unraveled the Mystery Behind the Gigantic Size of Extinct Ground Sloths—and What Led to Their Demise

    65 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Metabolic Messengers: The Role of Oestradiol

Pulmonary T2* MRI: New Fetal Lung Assessment Tool?

Digital Platform Boosts CPEC Disaster Resilience, Innovation

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.